Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Oct 1;39(37):3451-3453.
doi: 10.1093/eurheartj/ehy558.

Why do we care about coronary microvascular dysfunction and heart failure with preserved ejection fraction: addressing knowledge gaps for evidence-based guidelines

Affiliations
Comment

Why do we care about coronary microvascular dysfunction and heart failure with preserved ejection fraction: addressing knowledge gaps for evidence-based guidelines

Janet Wei et al. Eur Heart J. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Potential pathophysiological mechanisms linking CMD to HFpEF. The power of cardiac magnetic resonance imaging/magnetic resonance spectroscopy to define key pathophysiological mechanisms linking coronary microvascular dysfunction-related myocardial ischaemia to heart failure with preserved ejection fraction. Top illustrates traditional invasive measures of CMD (A), and resultant subendocardial ischaemia measured by first-pass perfusion magnetic resonance imaging and altered myocardial bioenergetics measured by 31P magnetic resonance spectroscopy (B). (CE) illustrate three proposed mechanistic pathways linking coronary microvascular dysfunction-related ischaemia to heart failure with preserved ejection fraction, including cardiac steatosis-induced lipotoxicity (C), adverse remodeling (D), and impaired systolic and diastolic function (E). The red arrows indicate directionality (cause and effect), with black question marks highlighting knowledge gaps for investigation. Note both the simple cause–effect relationship in some cases (e.g. ischaemia-related adverse remodeling), as well as more complex relationships involving multiple pathways. Importantly, cardiac magnetic resonance imaging/magnetic resonance spectroscopy is ideally situated to address all of the proposed mechanistic pathways. 2,3-DPG: 2-3-diphosphoglycerate; ATP: adenosine triphosphate; CMD, coronary microvascular dysfunction; cardiac magnetic resonance imaging/spectroscopy, HFpEF, heart failure with preserved ejection fraction; LA, left atrium; LGE, late gadolinium enhancement; LV, left ventricle; PCr, phosphocreatine; RV, right ventricle; TG, triglyceride.

Comment on

References

    1. Nelson MD, Wei J, Bairey Merz CN.. Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg? Eur Heart J 2018;39:850–852. - PMC - PubMed
    1. Shah SJ, Lam CSP, Svedlund S, Saraste A, Hage C, Tan R-S, Beussink-Nelson L, Fermer ML, Broberg MA, Gan L-M, Lund LH. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 2018;39:3439–3450. - PMC - PubMed
    1. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM.. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010;56:845–854. - PMC - PubMed
    1. Bairey Merz CN, Pepine CJ, Walsh MN, Fleg JL.. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation 2017;135:1075–1092. - PMC - PubMed
    1. Zheng SL, Chan FT, Nabeebaccus AA, Shah AM, McDonagh T, Okonko DO, Avis S.. Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Heart 2018;104:407–415. - PMC - PubMed

Publication types